Engrail Therapeutics Stock
HealthTechLooking to sell Engrail Therapeutics stock or options?
Engrail Therapeutics develops transformative medicines aimed at alleviating the significant impact of nervous system diseases. The company's solutions focus on improving the lives of patients with life-limiting neurological conditions by merging biological insights with effective clinical solutions. Engrail Therapeutics is committed to creating and advancing a diverse portfolio of groundbreaking treatments, simplifying complex disease therapies, and ultimately helping patients lessen their overall disease burden.
Investors Include:
Abrdn, F-Prime Capital, Ysios Capital, RiverVest Venture Partners, Longwood Fund, Forbion, Vincent Cheung, Meng Gao, Norwest Venture Partners, Red Tree Venture Capital.